Dren Bio
Clinical trials sponsored by Dren Bio, explained in plain language.
-
New drug access for patients who Can't join trials
Disease control AVAILABLEThis program provides early access to the experimental drug Dibotatug (DR-01) for people who cannot join ongoing clinical studies. It is meant for eligible patients whose doctors request the drug. The goal is to offer treatment outside of a formal trial setting.
Sponsor: Dren Bio • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New hope for tough cancers: experimental drug DR-0202 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called DR-0202 in people with advanced solid tumors (like breast, lung, or prostate cancer) that have not responded to at least two prior treatments. The main goal is to check the drug's safety and find the right dose. About 96 participants…
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
New hope for rare blood cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug called DR-01 in adults with rare types of leukemia or lymphoma. The goal is to see if it is safe and can shrink tumors. About 200 people will take part in this early-stage trial.
Phase: PHASE1, PHASE2 • Sponsor: Dren Bio • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC